$2 Million Jury Verdict Returned in First Federal Transvaginal Mesh Implant Trial
It was reported this morning that a jury has returned a $2 million verdict for the injured plaintiff in the first federal transvaginal mesh implant trial. Among other things, the plaintiff was compensated for her bleeding and pain. The victim required two subsequent complicated surgeries to remove the device. Significant punitive damages were also awarded. […]
Time is Running Out – Protect Your Rights To Bring Your Claims For Injuries From Your Pelvic Mesh Implant
Many women experience pelvic organ prolapse, or collapse of the pelvic floor, following child birth, having a hysterectomy or menopause. With this condition, pelvic organs slip out of place, or even protrude from the body. Since the 1990’s, transvaginal mesh devices have been used as a treatment for pelvic organ prolapse in women and were […]
J&J continued to sell Gynemesh and Prolift implants for 9 months after FDA said to cease marketing
Johnson & Johnson has recently come under intense scrutiny from consumers and doctors alike after it was discovered that it continued to sell a vaginal mesh implant (Gynecare Prolift) for nine months after U.S. regulators told the company to stop marketing the device. The implant, which surgeons thread through vaginal incisions to treat incontinence or […]
J&J continued to sell Gynemesh and Prolift implants for 9 months after FDA said to cease marketing
Johnson & Johnson has recently come under intense scrutiny from consumers and doctors alike after it was discovered that it continued to sell a vaginal mesh implant (Gynecare Prolift) for nine months after U.S. regulators told the company to stop marketing the device. The implant, which surgeons thread through vaginal incisions to treat incontinence or […]
Case management in MDLs 2325 (AMS), 2326 (Boston Scientific), & 2327 (Ethicon)
Judge Goodwin’s Daybook Entries of May 24, 2012, contain a case management section applicable to the AMS, Boston Scientific and Ethicon vaginal mesh injury cases, and states: MDL Nos. 2325 (AMS), 2326 (Boston Scientific), and 2327 (Ethicon): • Direct Filling Order. • Protective Order; the Protective Order entered in the Bard MDL will be the […]
Case management in MDLs 2325 (AMS), 2326 (Boston Scientific), & 2327 (Ethicon)
Judge Goodwin’s Daybook Entries of May 24, 2012, contain a case management section applicable to the AMS, Boston Scientific and Ethicon vaginal mesh injury cases, and states: MDL Nos. 2325 (AMS), 2326 (Boston Scientific), and 2327 (Ethicon): • Direct Filling Order. • Protective Order; the Protective Order entered in the Bard MDL will be the […]
Status of MDL 2326 Boston Scientific Pelvic Repair Litigation
On May 24, 2012, Judge Goodwin’s Daybook Entries reflect that the following matters were discussed in the Boston Scientific vaginal mesh injury litigation: • Pending Motions to Dismiss. • Boston Scientific Corporations Request for Science Day. • Discussion of ESI Protocol, Pltf and Deft Fact Sheets, Coordination of Discovery with Massachusetts. Boston Scientific’s science day […]
Status of MDL 2325 American Medical Systems Pelvic Repair Litigation
At a regularly scheduled status conference on May 25, 2012, in the federal multi-district litigation status conference, Judge Goodwin noted the follwing in his Daybook Entry: MDL No. 2325: • AMS Request for Science Day; scheduled for July 26, 2012 @ 10:00 a.m. • Counsel for Boston Scientific Corp will be permitted to make a […]
J&J Irresponsibly Fails to Recall Vaginal Mesh Implants
In response to an increase in the amount of reported injuries and lawsuits resulting from surgical mesh implants, Johnson & Johnson has decided to stop selling the product used to treat women’s health problems. The company expressed its desire to do so in a letter sent to judges in New Jersey and West Virginia who […]
J&J Irresponsibly Fails to Recall Vaginal Mesh Implants
In response to an increase in the amount of reported injuries and lawsuits resulting from surgical mesh implants, Johnson & Johnson has decided to stop selling the product used to treat women’s health problems. The company expressed its desire to do so in a letter sent to judges in New Jersey and West Virginia who […]
